Sort
261,768 grants matching “gene therapy”
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$2,100,313Pamela J Bjorkman · California Institute Of Technology · P01 · FY2015 · AI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$2,100,311Pamela J Bjorkman · California Institute Of Technology · P01 · FY2017 · AI
Translational Evaluation of PET Radiotracers
$2,100,167Robert Innis · National Institute Of Mental Health · ZIA · FY2023 · MH
Molecular Mechanism of Action of Phorbol Ester
$2,099,708Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
DNA Vaccines
$2,099,304George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
$2,099,091Howard S. Fox · University Of Nebraska Medical Center · U01 · FY2023 · DA
MicroRNAs for therapy of visual disorders
$2,099,016Martin Friedlander · Scripps Research Institute, The · R24 · FY2015 · EY
Diet, genetics, and CVD risk factor response in Blacks
$2,098,725Lsu Pennington Biomedical Research Ctr · U01 · FY2002 · HL
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$2,098,337Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Early Events in Alzheimer Pathogenesis
$2,098,315Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2017 · AG
Early Events in Alzheimer Pathogenesis
$2,098,315Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2020 · AG
Early Events in Alzheimer Pathogenesis
$2,098,315Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2019 · AG
Skeletal Disorders and Mineral Homeostasis Section
$2,098,226Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
The Delta Ecology of NSCLC Treatment
$2,097,825Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
$2,097,704Michael M. Shen · Columbia University Health Sciences · P01 · FY2025 · CA
Center on the Physics of Cancer Metabolism
$2,097,676Claudia Fischbach · Cornell University · U54 · FY2020 · CA
SPORE in Lung Cancer
$2,097,159Stephen B Baylin · Johns Hopkins University · P50 · FY2011 · CA
Chronic Rhinosinusitis Integrative Studies Program (CRISP)
$2,096,810Robert P Schleimer · Northwestern University At Chicago · U19 · FY2014 · AI
Elafin Therapy for Lung Diseases
$2,096,783Marlene Rabinovitch · Stanford University · P01 · FY2014 · HL
Cancer transcriptome characterization using massively parallel DNA sequencing
$2,096,750Marco Antonio Marra · British Columbia Cancer Agency · U24 · FY2012 · CA
Targeting Pten - An Upstream, Downstream and Offstream Approach
$2,096,667Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA
Mouse models of stress disorders and addiction
$2,096,662Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA
Center for Multiple Myeloma Nanotherapy
$2,096,597Samuel Achilefu · Washington University · U54 · FY2019 · CA
Integrated Mechanisms of Cardiac Maladaptation
$2,095,954R John Solaro · University Of Illinois At Chicago · P01 · FY2019 · HL
Proof of concept and dose response of CAM-6019 for HFrEF patients
$2,095,748Kfir Umansky · Velakor Biotherapeutics, Inc. · R44 · FY2025 · HL